Growth Metrics

Exagen (XGN) Change in Accured Expenses (2018 - 2026)

Exagen filings provide 9 years of Change in Accured Expenses readings, the most recent being -$1.6 million for Q1 2026.

  • On a quarterly basis, Change in Accured Expenses fell 9.8% to -$1.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was $112000.0, a 193.33% increase, with the full-year FY2025 number at $251000.0, up 288.72% from a year prior.
  • Change in Accured Expenses hit -$1.6 million in Q1 2026 for Exagen, down from $681000.0 in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $1.2 million in Q3 2023 to a low of -$1.6 million in Q1 2026.
  • Median Change in Accured Expenses over the past 5 years was $89000.0 (2022), compared with a mean of -$20235.3.
  • Biggest five-year swings in Change in Accured Expenses: plummeted 645.45% in 2022 and later soared 903.37% in 2023.
  • Exagen's Change in Accured Expenses stood at -$1.3 million in 2022, then skyrocketed by 138.8% to $497000.0 in 2023, then skyrocketed by 102.62% to $1.0 million in 2024, then tumbled by 32.37% to $681000.0 in 2025, then tumbled by 328.63% to -$1.6 million in 2026.
  • The last three reported values for Change in Accured Expenses were -$1.6 million (Q1 2026), $681000.0 (Q4 2025), and $1.2 million (Q3 2025) per Business Quant data.